Get the latest delivered to your inbox
Privacy Policy

Now Reading

Cadbury's Climate Change Commitment Recognised As UK 'Best In Class'

Cadbury's Climate Change Commitment Recognised As UK 'Best In Class'

Published 10-08-08

Submitted by Biogen

- October 8, 2008 - Cadbury has been recognised as "Best in Class" in its approach to climate change in a report released today by the Carbon Disclosure Project which is a survey of the UK's FTSE 350 on the issue of climate change. This year, Cadbury is the only confectionery company included in the leadership index.

The annual survey of the FTSE 350 largest corporations was commissioned by a coalition of over 385 institutional investors representing more than $57 trillion in assets. The result is a Climate Disclosure Leadership Index from the companies which responded. Within the retail and consumer sector, the companies included showed distinction based on their reporting of greenhouse gas emissions and an independent assessment of their climate change strategies.

The Carbon Disclosure Project and Cadbury are also working together on the Supply Chain Leadership Collaboration (SCLC), which brings together sector leaders to measure and subsequently manage emissions through the supply chain. Cadbury’s supply chain has been reporting greenhouse gas emissions data, emissions reduction targets and climate change strategy through the CDP’s unified system.

Cadbury has been at the forefront of the global food manufacturing sector since the launch of its Purple Goes Green initiative in June 2007, which committed to a 50% absolute reduction in carbon emissions by 2020, and setting targets for packaging and water-use reduction.

Ian Walsh, Global Head of Environment, commented: "Sustainability is increasingly at the heart of all of our business decisions, and this survey confirms that climate change is now a boardroom, and not backroom, issue."

Ends

1. Media Enquires
Alison Ward: Alison.ward@csplc.com 07969 227 632

2. About Cadbury
Cadbury is a leading confectionery company, with a heritage of creating confectionery brands people love for nearly 200 years. Cadbury operates in over 60 countries with some of the world's best loved brands, including Trident, Dairy Milk, Halls and Bassett.

3. Background on Purple Goes Green

In June 2007, Cadbury announced its ground breaking environmental strategy, Purple Goes Green, which aims to reduce Cadbury's environmental footprint by cutting its energy use, reducing excess packaging and managing its water use.

Targets:

  • 50% reduction of net absolute carbon emissions by 2020 "“ with a minimum of 30% from in-company actions
  • 10% reduction in packaging used per tonne of product and 25% in the more highly packaged seasonal and gifting items
  • Use more environmentally sustainable forms of packaging - aim for 60% biodegradable, with 100% of secondary packaging being recyclable
  • All 'water scarce' sites to have water reduction programmes in place
These targets were developed with advice from Forum for the Future, the sustainable development charity.

4. Background on the Climate Disclosure Leadership Index
The Carbon Disclosure Project is a special project of Rockefeller Philanthropy Advisors in New York. Full details on CDP, the CDP reports and the responses from corporations can be found at www.cdproject.net

The FTSE 350 Report analyses the responses of the UK's 350 largest, listed companies by market capitalisation, the FTSE 350. The FTSE 100 and the FTSE 250 companies, which together form the FTSE 350, were also analysed.

The index, compiled by PricewaterhouseCoopers (PwC) on behalf of CDP, comprises 42 constituents of the FTSE 350 Index based on PwC's analysis of the responses to CDP's 2008 Questionnaire which focused on greenhouse gas emissions, emissions reduction targets and risks and opportunities associated with climate change.

Biogen Logo

Biogen

Biogen

Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease. Biogen is advancing a pipeline of potential novel therapies across neurology, neuropsychiatry, specialized immunology and rare diseases and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.

More from Biogen

Join today and get the latest delivered to your inbox